Study Forecasts 7.0% CAGR, with the CDMO Market Expanding from $136.6 Billion in 2024 to $191.6 Billion by 2029, Fueled by Increased Demand for Outsourced Drug Development and Manufacturing.Boston, ...
WuXi AppTec joined the Pharmaceutical Supply Chain Initiative ... The Bloc, a 2024 MM+M Agency 100 honoree, solidified its presence in Asia by unveiling its new office in Singapore. Repare ...
Hosted on MSN23d
China, Tech Outlooks Blunt Asian Stock MarketsLeading the thin upside was Hansoh Pharmaceutical, gaining 0.7%, while Wuxi AppTec declined 8.1% ... the Australian ASX 200 inclined 0.4%; the Singapore Straits Times Index rose 0.5%, and the ...
Hosted on MSN28d
Financial Services Roundup: Market TalkThe Singapore bank’s net interest margin may ... Jiangsu Hengrui Medicine drops 1.3% and WuXi AppTec falls 2.2%. Bank stocks are broadly higher, with Industrial & Commercial Bank of China ...
WuXi AppTec disclosed that it was unsure whether it would dispose ... Half of the company’s revenue will come from facilities outside China, such as the US and Singapore, by 2030, he predicted. Last ...
WuXi AppTec Co, Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene ...
WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...
WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released lower-than ...
Contract research organisation (CRO) NAMSA has acquired the US-based medical device testing operations of WuXi AppTec to strengthen its medtech clinical research testing capabilities. The deal ...
WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...
US intelligence services advised the authors of the BIOSECURE Act that that WuXi AppTec shared confidential data on US customers with the Chinese government, according to a Reuters report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results